Latest News and Press Releases
Want to stay updated on the latest news?
-
July 28, 2025News Release BioPorto attends the Association for Diagnostics & Laboratory Medicine meeting, where NGAL and Acute Kidney Injury will be a key focus among participants. Laboratory...
-
27. juni, 2025Meddelelse nr. 18 Påbegyndelse af kommercialisering af ProNephro AKITM (NGAL) til diagnostisk brug i USA KØBENHAVN, DANMARK og BOSTON, MA, USA, 27. juni 2025 – BioPorto A/S...
-
June 27, 2025Announcement no. 18 Initiation of commercialization of ProNephro AKITM (NGAL) for diagnostic use in the US COPENHAGEN, DENMARK and BOSTON, MA, USA, June 27, 2025 – BioPorto A/S...
-
12. juni 2025Meddelelse nr. 17 Tildeling af Warrants København, Danmark, den 12. juni 2025 (GLOBE NEWSWIRE) – Bestyrelsen...
-
12 June 2025 Announcement no. 17 Grant of Warrants Copenhagen, Denmark, June 12, 2025, (GLOBE NEWSWIRE) – The Board of...
-
10. juni, 2025Meddelelse nr. 16 BioPorto A/S annoncerer udnævnelsen af en ny administrerende direktør som en del af selskabets successionsstrategi KØBENHAVN, DANMARK og BOSTON, MA, USA, 10. juni,...
-
June 10, 2025Announcement no. 16 BioPorto A/S Announces the Appointment of a New CEO as Part of its Succession Planning Strategy COPENHAGEN, DENMARK and BOSTON, MA, USA, June 10, 2025, (GLOBE...
-
8. maj 2025Meddelelse nr. 15 Fortsat fremgang på vigtige strategiske milepæle i første kvartal af 2025. Den samlede omsætning...
-
May 8, 2025Announcement no. 15 Continued progress on key strategic milestones in Q1 2025. Total revenue in line with...
-
28. april 2025Meddelelse nr. 14 Tildeling af Warrants København, Danmark, den 28. april 2025 (GLOBE NEWSWIRE) – Bestyrelsen...